id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0018-15901,FDA,FDA-1978-N-0018,PASS Coalition Letter to FDA re CDER Meeting on Sunscreen Ingredients,Other,Letter(s),2025-03-20T04:00:00Z,2025,3,2025-03-20T04:00:00Z,,2025-03-20T20:57:55Z,,0,0,09000064868eb5e8
FDA-1978-N-0018-15902,FDA,FDA-1978-N-0018,EWG - FDA sunscreen meeting,Other,Letter(s),2025-03-20T04:00:00Z,2025,3,2025-03-20T04:00:00Z,,2025-03-20T21:00:04Z,,0,0,09000064868eb5ea
FDA-1978-N-0018-15900,FDA,FDA-1978-N-0018,Covington Withdrawal from OTC Sunscreen IWG,Other,Letter(s),2025-03-07T05:00:00Z,2025,3,2025-03-07T05:00:00Z,,2025-03-07T14:10:04Z,,0,0,09000064868eb2fb
FDA-1978-N-0018-15898,FDA,FDA-1978-N-0018,Sunscreen Work Plan_Advice Letter for CHPA,Other,Letter(s),2025-03-06T05:00:00Z,2025,3,2025-03-06T05:00:00Z,,2025-03-06T15:26:40Z,,0,0,09000064868e6f87
FDA-1978-N-0018-15899,FDA,FDA-1978-N-0018,CHPA sunscreen consortium letter to FDA,Other,Letter(s),2025-03-06T05:00:00Z,2025,3,2025-03-06T05:00:00Z,,2025-03-06T15:26:44Z,,0,0,09000064868e6f89
FDA-1978-N-0018-15897,FDA,FDA-1978-N-0018,EWG_Listening Session_Meeting Minutes,Other,Minutes,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-23T17:46:39Z,,0,0,09000064868d037f
FDA-1978-N-0018-15890,FDA,FDA-1978-N-0018,Clinical and Nonclinical Safety Work Plan for Active Ingredients in OTC Sunscreen Drug Products_Integral Consulting,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-04-16T14:49:34Z,,0,0,09000064868cfb3a
FDA-1978-N-0018-15891,FDA,FDA-1978-N-0018,Integral Consulting Withdrawal from OTC Sunscreen IWG - Letter to FDA,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-17T21:39:29Z,,0,0,09000064868cfb3c
FDA-1978-N-0018-15893,FDA,FDA-1978-N-0018,Sunscreen Work Plan_FDA Second Advice Letter to Covington & Burling LLP,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-17T21:39:36Z,,0,0,09000064868cfb40
FDA-1978-N-0018-15896,FDA,FDA-1978-N-0018,EWG Listening Session Request,Other,Meeting,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-23T17:44:00Z,,0,0,09000064868d037d
FDA-1978-N-0018-15894,FDA,FDA-1978-N-0018,PASS Listening Session Request,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-23T17:39:32Z,,0,0,09000064868d0379
FDA-1978-N-0018-15895,FDA,FDA-1978-N-0018,AADA Listening Session Request,Other,Meeting,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-23T17:42:09Z,,0,0,09000064868d037b
FDA-1978-N-0018-15892,FDA,FDA-1978-N-0018,Sunscreen Work Plan_FDA Advice Letter to Covington & Burling LLP,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-17T21:39:33Z,,0,0,09000064868cfb3e